Quad.bio is a privately-owned biopharmaceutical company based in Irvine, California focused on licensing and commercializing anti-cancer drugs that address high unmet medical needs. Quad.bio has two unique assets currently in IND-enabling studies, including nuc-Gemcitabine, and a highly potent MERTK/AXL/pan-cMET kinase inhibitor.
Company Details
- Founded
- 2019
- Address
- High Unmet Medical Needs. Quad.bio Has Two Unique Assets Currently In Ind-Enabling Studies
- Phone
- 832-975-8840
- in****@****ope.bio
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- hopebiosci.com
- Keywords
- Oncology, Cancer, Drug development.
Quad.bio Questions
Quad.Bio's helpline number is 832-975-8840
Quad.Bio's website is hopebiosci.com
Quad.Bio's LinkedIn profile is https://www.linkedin.com/company/hope-biosciences
Quad.Bio's industry is
Biotechnology Research
Quad.Bio's top competitors are
Epigen Biosciences, Inc.,
Telesis Therapeutics, Inc.,
Renbiologics,
Neox Biotech,
Hope Medicine Inc,
Mc Sciences,
Novamab,
Rezq Bio,
New Perspectives, Inc.,
Mirabiologics Inc..
Quad.Bio's support email address is info@hope.bio
Quad.Bio's categories are Biotechnology Research
Quad.Bio's founding year is 2019
